Clinical and Molecular Epidemiology of Carbapenem-Resistant Enterobacteriaceae Among Adult Inpatients in Singapore.
暂无分享,去创建一个
Oon Tek Ng | Barnaby Young | Kalisvar Marimuthu | Rick Twee-Hee Ong | Indumathi Venkatachalam | Jia Jun Lee | Li Yang Hsu | Prabha Unny Krishnan | Tse Hsien Koh | Y. Teo | R. Lin | D. Fisher | T. Tan | R. Ong | L. Hsu | J. Teo | B. Young | O. Ng | K. Marimuthu | I. Venkatachalam | E. Tan | S. Pada | Dale Fisher | Yik-Ying Teo | K. Thoon | A. Kurup | T. Koh | Raymond Tzer Pin Lin | Asok Kurup | Thean Yen Tan | Moi Lin Ling | Say Tat Ooi | P. Krishnan | W. Khong | Wei Xin Khong | Choong-Weng Lam | Eng Lee Tan | S. Ooi | Koh Cheng Thoon | Benjamin Pei Zhi Cherng | My Van La | Partha Pratim De | Raymond Fong Kok Choon | Surinder Kaur Pada | Choong Weng Lam | Rama Narayana Deepak | Nares Smitasin | Nancy Tee Wen Sim | Brenda Ang Sze Peng | Jeanette Teo | P. De | M. Ling | B. Cherng | N. Smitasin | R. N. Deepak | N. W. Sim | My Van La
[1] R. Lynfield,et al. Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013. , 2015, JAMA.
[2] P. Nordmann,et al. OXA-48-like carbapenemases: the phantom menace. , 2012, The Journal of antimicrobial chemotherapy.
[3] Gopi Patel,et al. Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies , 2008, Infection Control & Hospital Epidemiology.
[4] A. Carattoli,et al. Patient risk factors for outer membrane permeability and KPC-producing carbapenem-resistant Klebsiella pneumoniae isolation: results of a double case–control study , 2013, Infection.
[5] N. Woodford,et al. KPC enzymes in the UK: an analysis of the first 160 cases outside the North-West region. , 2016, The Journal of antimicrobial chemotherapy.
[6] I. Kassis,et al. Carbapenem Resistance Among Klebsiella pneumoniae Isolates Risk Factors, Molecular Characteristics, and Susceptibility Patterns , 2009, Infection Control & Hospital Epidemiology.
[7] Y. Carmeli,et al. An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] N. Woodford,et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study , 2010, The Lancet. Infectious diseases.
[9] Yehuda Carmeli,et al. Predictors of Carbapenem-Resistant Klebsiella pneumoniae Acquisition among Hospitalized Adults and Effect of Acquisition on Mortality , 2007, Antimicrobial Agents and Chemotherapy.
[10] Evangelos I. Kritsotakis,et al. Antibiotic use and the risk of carbapenem-resistant extended-spectrum-{beta}-lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study. , 2011, The Journal of antimicrobial chemotherapy.
[11] Kim F. Wong,et al. Vital Signs: Estimated Effects of a Coordinated Approach for Action to Reduce Antibiotic-Resistant Infections in Health Care Facilities — United States , 2015, MMWR. Morbidity and mortality weekly report.
[12] Fotini C Chelvatzoglou,et al. Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study. , 2007, The Journal of antimicrobial chemotherapy.
[13] N. Woodford,et al. Carbapenem-hydrolysing IMP-1 β-lactamase in Klebsiella pneumoniae from Singapore , 1999, The Lancet.
[14] Hui Wang,et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. , 2013, The Lancet. Infectious diseases.
[15] Jia Jun Lee,et al. Tracking inter-institutional spread of NDM and identification of a novel NDM-positive plasmid, pSg1-NDM, using next-generation sequencing approaches. , 2016, The Journal of antimicrobial chemotherapy.
[16] P. Nordmann,et al. The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[17] R. Lin,et al. Klebsiella pneumoniae Carbapenemase-producing Enterobacteria in Hospital, Singapore , 2012, Emerging infectious diseases.
[18] S. Choi,et al. Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumoniae among hospitalized patients. , 2005, Microbial drug resistance.
[19] S. Choi,et al. Risk factors for the acquisition of carbapenem-resistant Escherichia coli among hospitalized patients. , 2006, Diagnostic microbiology and infectious disease.
[20] Y. Carmeli,et al. Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] P. Harris,et al. Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.
[22] R. Jureen,et al. OXA-181-producing Klebsiella pneumoniae establishing in Singapore , 2013, BMC Infectious Diseases.
[23] R. Lin,et al. Molecular characterization of NDM-1 producing Enterobacteriaceae isolates in Singapore hospitals. , 2012, Western Pacific surveillance and response journal : WPSAR.